Weina Sun

MedicineAgricultural and Biological Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 30 papers. Top paper: “Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate”.

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate

EBioMedicine(2020)10.1016/j.ebiom.2020.103132

N/A

2.7DataRank · unranked

117 citations

Sarah R. Leist, Stephen McCroskery, Yonghong Liu, Stefan Slamanig, Justine Oliva +8 more

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial

EClinicalMedicine(2022)10.1016/j.eclinm.2022.101323

N/A

1.3DataRank · unranked

55 citations

Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn +42 more

Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico

npj Vaccines(2023)10.1038/s41541-023-00662-6

N/A

1.1DataRank · unranked

47 citations

Martha Torres, Luis Enrique Soto-Ramírez, Juan J. Calva, Patricio Santillán‐Doherty, Dora Eugenia Carranza-Salazar +28 more

Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico

medRxiv(2022)10.1101/2022.02.08.22270676

N/A

1.1DataRank · unranked

26 citations

Martha Torres, Luis Enrique Soto-Ramírez, Juan J. Calva, Patricio Santillán‐Doherty, Dora Eugenia Carranza-Salazar +28 more

Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination

Cell Reports(2024)10.1016/j.celrep.2024.114922

N/A

0.805DataRank · unranked

37 citations

Irene Hoxie, Daniel C. Adelsberg, Iden A. Sapse, Robert Andreata‐Santos, Jeremy S. Yong +14 more

Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial

medRxiv(2021)10.1101/2021.09.17.21263758

N/A

0.486DataRank · unranked

8 citations

Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn +41 more

An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody

mBio(2023)10.1128/mbio.02477-23

N/A

0.444DataRank · unranked

8 citations

Luca Brambilla, Daniel C. Adelsberg, Shreyas Kowdle, Christian S. Stevens, Stefan Slamanig +11 more

Discovery of a SARS-CoV-2 Broadly-Acting Neutralizing Antibody with Activity against Omicron and Omicron + R346K Variants

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.01.19.476998

N/A

0.330DataRank · unranked

8 citations

Thomas Kraus, Heyue Zhou, Yanliang Zhang, Namir Shaabani, Soner Yildiz +43 more

A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.30.229120

N/A

0DataRank · unranked

40 citations

Stephen McCroskery, Wen‐Chun Liu, Sarah R. Leist, Yonghong Liu, Randy A. Albrecht +11 more

Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants

Med(2022)10.1016/j.medj.2022.08.002

N/A

0DataRank · unranked

23 citations

Thomas Kraus, Heyue Zhou, Yanliang Zhang, Namir Shaabani, Soner Yildiz +44 more

Safety and Immunogenicity of An Egg-Based Inactivated Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomized, Placebo-Controlled, Phase 1/2 Trial in Vietnam

medRxiv(2022)10.1101/2022.02.01.22270253

N/A

0DataRank · unranked

3 citations

Vũ Đình Thiểm, Ha Hai Vu, Van Thanh Ta, Anh Thi Van Pham, Mai Thị Ngọc Đặng +28 more

Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.21.485247

N/A

0DataRank · unranked

3 citations

José Luis Martínez, Stefan Slamanig, Nicholas Lemus, Yonghong Liu, Tsoi Ying Lai +11 more

Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals

Journal of Virology(2020)10.1128/jvi.00742-20

N/A

0DataRank · unranked

26 citations

Weina Sun, Xiaoli Xiong, Alec W. Freyn, Julia Peukes, Shirin Strohmeier +5 more

Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice

EBioMedicine(2024)10.1016/j.ebiom.2024.105185

N/A

0DataRank · unranked

18 citations

Irene González‐Domínguez, Lauren A. Chang, Nicholas Lemus, Tsoi Ying Lai, José Luis Martínez +13 more

Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity

npj Vaccines(2024)10.1038/s41541-024-00952-7

N/A

0DataRank · unranked

10 citations

Lauren A. Chang, Rebecca L. Pearl, Sonia Jangra, Amy Aspelund, Alaura Hoag +15 more

Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach

npj Vaccines(2024)10.1038/s41541-024-01014-8

N/A

0DataRank · unranked

8 citations

Eduard Puente‐Massaguer, Adam Abdeljawad, Tsoi Ying Lai, Yonghong Liu, Madhumathi Loganathan +10 more

The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex

Vaccine(2024)10.1016/j.vaccine.2024.04.037

N/A

0DataRank · unranked

8 citations

Nicholas Lemus, Tsoi Ying Lai, Mitali Mishra, Irene González‐Domínguez, Eduard Puente‐Massaguer +9 more

Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.28.582613

N/A

0DataRank · unranked

9 citations

Irene Hoxie, Daniel C. Adelsberg, Iden A. Sapse, Robert Andreata‐Santos, Jeremy S. Yong +14 more

SARS-CoV-2 Nsp15 antagonizes the cGAS-STING-mediated antiviral innate immune responses

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.05.611469

N/A

0DataRank · unranked

5 citations

Yao Yu Yeo, Tsoi Ying Lai, Chuan-Tien Hung, Shreyas Kowdle, Griffin D. Haas +4 more

PUM2 binds SARS-CoV-2 RNA and PUM1 mildly reduces viral RNA levels, but neither protein affects progeny virus production

Journal of General Virology(2025)10.1099/jgv.0.002152

N/A

0DataRank · unranked

2 citations

Yelizaveta Zaytseva, Chia-Ching Lin, Mitali Mishra, Weina Sun, Paulina Pawlica +1 more

Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1

Scientific Reports(2025)10.1038/s41598-025-26149-z

N/A

0DataRank · unranked

1 citations

Priyanka Gadam Rao, Juan C. Bandrés, Ismael Pena, Katherine Bolanos Roldan, Gagandeep Singh +8 more

Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG and BA.3.2 following KP.2 monovalent mRNA vaccination

medRxiv(2025)10.1101/2025.08.24.25333689

N/A

0DataRank · unranked

6 citations

Brian Lerman, Jordan Ehrenhaus, Brian Monahan, Gagandeep Singh, Adria Wilson +13 more

Enhancing protective efficacy and immunogenicity of hemagglutinin-based influenza vaccine utilizing adjuvants developed by BECC

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.03.657703

N/A

0DataRank · unranked

1 citations

Brandon M Tenaglia, Devon Riley, Sydney Speed, Lauren Baracco, Francesca M. Gardner +10 more

PUM2 binds SARS-CoV-2 RNA and PUM1 mildly reduces viral RNA levels, but neither protein affects progeny virus production

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.23.661172

N/A

0DataRank · unranked

0 citations

Yelizaveta Zaytseva, Chia-Ching Lin, Mitali Mishra, Weina Sun, Paulina Pawlica +1 more

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.26.221861

N/A

0DataRank · unranked

11 citations

Sarah R. Leist, Stephen McCroskery, Yonghong Liu, Stefan Slamanig, Justine Oliva +8 more

Immunogenicity and efficacy of homologous and heterologous NDV and MVA SARS-CoV-2 vaccines in mice and hamsters

npj Vaccines(2025)10.1038/s41541-025-01299-3

N/A

0DataRank · unranked

0 citations

Kaijun Jiang, Irene González‐Domínguez, Daniel Rodríguez-Martín, Adam Abdeljawad, Anastasija Čupić +11 more

Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice

Frontiers in Immunology(2021)10.3389/fimmu.2021.746447

N/A

0DataRank · unranked

23 citations

Shirin Strohmeier, Irene González‐Domínguez, Jessica Tan, Viviana Simon, Florian Krammer +4 more

An egg-derived sulfated N-Acetyllactosamine glycan is an antigenic decoy of influenza virus vaccines

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.16.435673

N/A

0DataRank · unranked

2 citations

Henry A. Utset, Carole Henry, Lei Li, Nai‐Ying Zheng, Weina Sun +8 more

Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice

Microbiology Spectrum(2022)10.1128/spectrum.01538-22

N/A

0DataRank · unranked

42 citations

José Luis Martínez, Stefan Slamanig, Nicholas Lemus, Yonghong Liu, Tsoi Ying Lai +12 more

A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice

Molecular Therapy(2022)10.1016/j.ymthe.2022.01.011

N/A

0DataRank · unranked

41 citations

Alec W. Freyn, Tom G. Caniels, Victor H. Leyva-Grado, Raffael Nachbagauer, Weina Sun +8 more